Swipe to see the answers and explanations!
#DLBCL #DiffuseLargeBCellLymphoma #DoubleHitLymphoma #MYC #BCL2 #Polatuzumab #PolaRCHP #Lymphoma #Hematology #HemeOnc #Oncology #ClinicalHematology #MedicalEducation #MedEd #HemeHub
Swipe to see the answers and explanations!
#DLBCL #DiffuseLargeBCellLymphoma #DoubleHitLymphoma #MYC #BCL2 #Polatuzumab #PolaRCHP #Lymphoma #Hematology #HemeOnc #Oncology #ClinicalHematology #MedicalEducation #MedEd #HemeHub
MYC rearrangements, double-hit/triple-hit lymphoma, double expressor status, CD5+ DLBCL, and genetic subtypes that further refine prognosis.
#DLBCL #DiffuseLargeBCellLymphoma #DoubleHitLymphoma #MYC #BCL2 #BCL6 #Oncology #ClinicalHematology #HemeHub
MYC rearrangements, double-hit/triple-hit lymphoma, double expressor status, CD5+ DLBCL, and genetic subtypes that further refine prognosis.
#DLBCL #DiffuseLargeBCellLymphoma #DoubleHitLymphoma #MYC #BCL2 #BCL6 #Oncology #ClinicalHematology #HemeHub